GA-VMTD (hereditary TTP) AA-VMTD (autoimmune TTP) | EA-VMTD without HC (chronic “DIC”) | EA-VMTD with HC due to acute liver necrosis (acute “DIC”) | Fibrin clot disease (True DIC) (e.g., APL) | Primary fibrinolysis (e.g., amyloidosis) | |
---|---|---|---|---|---|
Hematologic features | |||||
Thrombosis form | Microthrombi | Microthrombi | Microthrombi | Fibrin clots | NA |
Hemostatic path | Aberrant ULVWF path | ULVWF path | ULVWF path | Aberrant TF path | NA |
Thrombocytopenia | Always present | Variably present | Commonly present | Present due to APL | Not present |
MAHA | Always present | Commonly present | Commonly present | Not present | Not present |
MODS | Often present (brain and kidneys) | Often present | Often present | Not present | Not present |
Acute liver failure | Uncommon (?) | Not present | Always present | Not present | ? |
Hemorrhage | Typically do not occur | Do not occur | Typically occur | Commonly occur | Persistent bleeding |
Coagulation factors | |||||
Fibrinogen | Normal | Normal | Increased (early phase) decreased (late phase) | Decreased | Markedly decreased |
FVIII | Normal | Markedly increased | Markedly increased | Markedly decreased | Decreased |
FV | Normal | Normal | Decreased | Decreased | Normal to decreased |
FVII | Normal | Normal | Markedly decreased | Normal | Normal |
D-dimer/FDP | Normal | Normal | Increased | Increased | Increased |
VWF/ULVWF | Normal | Markedly increased | Markedly increased | ? | ? |
Coagulation tests | |||||
aPTT | Normal | Normal | Markedly prolonged | Markedly prolonged | Prolonged |
PT | Normal | Normal | Markedly prolonged | Prolonged | Prolonged |